New stem cell therapy aims to ease hardening skin disease
NCT ID NCT07535931
First seen Apr 30, 2026 · Last updated Apr 30, 2026
Summary
This early-stage trial tests a new stem cell treatment (HS_SW01) for people with systemic sclerosis, a disease that causes skin hardening and organ damage. The main goal is to see if the treatment is safe and tolerable in 21 adults aged 18-65. Researchers will also check if it improves skin thickness and how the body responds to the cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.